Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aqua Medical
Pleasanton, California, United Statesaquaendoscopy.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Aqua Medical's radiofrequency vapor ablation system is being evaluated in multiple pilot human studies as a minimally invasive endoscopic treatment to improve glycemic control in patients with type 2 diabetes. Early results focus on safety, tolerability, and effectiveness of duodenal mucosal ablation. The technology aims to reduce or eliminate insulin dependence by altering the metabolic function of the gut lining. No pivotal or commercial-stage data yet available.
- Therapeutic areas
- OncologyEndocrinologyGastroenterology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Aqua Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aqua Medical.